Miyamoto T, Fukase N, Kawamoto T, Fujiwara S, Hara H, Sawada R
Oncol Rep. 2024; 53(2).
PMID: 39704263
PMC: 11667212.
DOI: 10.3892/or.2024.8857.
Lv L, Miao Q, Zhan S, Chen P, Liu W, Lv J
J Immunother Cancer. 2024; 12(12).
PMID: 39694700
PMC: 11660338.
DOI: 10.1136/jitc-2024-009444.
Wang Y, Tian X, Wang Z, Liu D, Zhao X, Sun X
Clin Transl Med. 2024; 14(8):e1801.
PMID: 39107881
PMC: 11303264.
DOI: 10.1002/ctm2.1801.
Lubachowski M, VanGenderen C, Valentine S, Belak Z, Davies G, Arnason T
Cancers (Basel). 2024; 16(9).
PMID: 38730707
PMC: 11083742.
DOI: 10.3390/cancers16091755.
Elfoly M, Mirza J, Alaiya A, Al-Hazzani A, Tulbah A, Al-Alwan M
Cancer Cell Int. 2024; 24(1):161.
PMID: 38725021
PMC: 11084005.
DOI: 10.1186/s12935-024-03354-w.
Targeting RCC1 to block the human soft-tissue sarcoma by disrupting nucleo-cytoplasmic trafficking of Skp2.
Zhuang M, Li F, Liang H, Su Y, Cheng L, Lin B
Cell Death Dis. 2024; 15(4):241.
PMID: 38561375
PMC: 10985091.
DOI: 10.1038/s41419-024-06629-2.
SKping cell cycle regulation: role of ubiquitin ligase SKP2 in hematological malignancies.
William J, Dhar R, Gundamaraju R, Sahoo O, Pethusamy K, Raj A
Front Oncol. 2024; 14:1288501.
PMID: 38559562
PMC: 10978726.
DOI: 10.3389/fonc.2024.1288501.
Role of Akt/Protein Kinase B in Cancer Metastasis.
Islam M, Jones S, Ellis I
Biomedicines. 2023; 11(11).
PMID: 38002001
PMC: 10669635.
DOI: 10.3390/biomedicines11113001.
Characterizing citrullination by mass spectrometry-based proteomics.
Rebak A, Hendriks I, Nielsen M
Philos Trans R Soc Lond B Biol Sci. 2023; 378(1890):20220237.
PMID: 37778389
PMC: 10542455.
DOI: 10.1098/rstb.2022.0237.
FOXO transcription factors as mediators of stress adaptation.
Rodriguez-Colman M, Dansen T, Burgering B
Nat Rev Mol Cell Biol. 2023; 25(1):46-64.
PMID: 37710009
DOI: 10.1038/s41580-023-00649-0.
Somatic gain-of-function mutations in BUD13 promote oncogenesis by disrupting Fbw7 function.
Chen J, Zhang X, Tan X, Liu P
J Exp Med. 2023; 220(10).
PMID: 37382881
PMC: 10309187.
DOI: 10.1084/jem.20222056.
TRAF6 Promotes PRMT5 Activity in a Ubiquitination-Dependent Manner.
Liu L, Yin S, Gan W
Cancers (Basel). 2023; 15(9).
PMID: 37173967
PMC: 10177089.
DOI: 10.3390/cancers15092501.
Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review.
Jing J, Rui L, Junyuan S, Jinfeng Y, Zhihao H, Weiguo L
Front Pharmacol. 2023; 14:1122008.
PMID: 37089937
PMC: 10113621.
DOI: 10.3389/fphar.2023.1122008.
Pharmacological inhibition of the SKP2/p300 signaling axis restricts castration-resistant prostate cancer.
Rezaeian A, Phan L, Zhou X, Wei W, Inuzuka H
Neoplasia. 2023; 38:100890.
PMID: 36871351
PMC: 10006859.
DOI: 10.1016/j.neo.2023.100890.
SKP2 Contributes to AKT Activation by Ubiquitination Degradation of PHLPP1, Impedes Autophagy, and Facilitates the Survival of Thyroid Carcinoma.
Shao Y, Ren W, Dai H, Yang F, Li X, Zhang S
Mol Cells. 2023; 46(6):360-373.
PMID: 36694914
PMC: 10258456.
DOI: 10.14348/molcells.2022.2242.
High Expression of Casein Kinase 2 Alpha Is Responsible for Enhanced Phosphorylation of DNA Mismatch Repair Protein MLH1 and Increased Tumor Mutation Rates in Colorectal Cancer.
Ulreich K, Firnau M, Tagscherer N, Beyer S, Ackermann A, Plotz G
Cancers (Basel). 2022; 14(6).
PMID: 35326704
PMC: 8946085.
DOI: 10.3390/cancers14061553.
ACK1 upregulated the proliferation of head and neck squamous cell carcinoma cells by promoting p27 phosphorylation and degradation.
Peng H, Yang H, Rupa D, Yen C, Chiu Y, Yang W
J Cell Commun Signal. 2022; 16(4):567-578.
PMID: 35247157
PMC: 9733751.
DOI: 10.1007/s12079-022-00670-6.
Regulation of SKP2 protein stability by heat shock protein 90 chaperone machinery.
Cai L, Li L, Chen X, Jia L
Signal Transduct Target Ther. 2021; 6(1):276.
PMID: 34326309
PMC: 8322090.
DOI: 10.1038/s41392-021-00624-1.
Cell cycle on the crossroad of tumorigenesis and cancer therapy.
Liu J, Peng Y, Wei W
Trends Cell Biol. 2021; 32(1):30-44.
PMID: 34304958
PMC: 8688170.
DOI: 10.1016/j.tcb.2021.07.001.
Akt Isoforms: A Family Affair in Breast Cancer.
Basu A, Lambring C
Cancers (Basel). 2021; 13(14).
PMID: 34298660
PMC: 8306188.
DOI: 10.3390/cancers13143445.